98%
921
2 minutes
20
Metallic Zn represents as a primary choice in fabricating various aqueous Zn-ion batteries (ZIBs), however challenging issues including dendrite growth and parasitic reactions at the anode/electrolyte interface, considerably hamper its practical implementation in large-scale energy storage. Herein, we report a low-cost multifunctional ion rectifier (IRT) as an artificial intermediate to reform Zn anode, which can practically eliminate the above issues. The hydrophobic shell (polyvinylidene difluoride) can suppress Zn interfacial corrosion with an inhibition efficiency of 94.8% by repelling water molecules from the bulk electrolyte. Additionally, negatively-charged ion channels inside the zincophilic core (ultrathin vermiculite sheets) induce de-solvating redistribution effect on Zn ions flux, enabling a high ions transference number (0.79) for dendrite-free Zn deposition. This leads to exceptional Zn/Zn reversibility in metallic Zn with IRT stabilization. The remarkable Coulombic efficiency (99.8%, 2000 cycles) for asymmetrical batteries, and a long lifespan (1600 h) with ultrahigh cumulative capacity of 2400 mAh cm for symmetrical batteries, are successfully achieved. More encouragingly, the Zn//NHVO pouch cell retains 94.3% of its original capacity after 150 cycles at 1 A g. We believe that this low-cost and high-efficiency tactic could pave a promising path for anode surface modification.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scib.2023.05.015 | DOI Listing |
J Nanobiotechnology
September 2025
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
As the second most common cause of death globally, tumor significantly impacts human health and quality of life. Although monotherapy has achieved remarkable progress, its therapeutic effectiveness remains less than ideal. The current strategy is increasingly inclined towards a combination of different treatments.
View Article and Find Full Text PDFInt J Biol Macromol
August 2025
Drug Discovery and Development Laboratory (DDD Lab), Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India. Electronic address:
GIRK channels are crucial in regulating cardiac excitability and present promising therapeutic targets. Notably, the genetic absence of GIRK4 prevents atrial fibrillation (AF) in knockout mice, yet research on specific GIRK4 modulators is limited. Addressing the challenges posed by GIRK4's intrinsic constitutive activity, we hypothesize that a GIRK inverse agonist unlike the traditional antagonist can actively downregulate the channel activity alongside reduction of the aberrant basal signaling which can translate to enhanced therapeutic efficacy.
View Article and Find Full Text PDFCells
August 2025
Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) tend to show a mixed population of action potential (AP) types, including atrial-like (A-like) and ventricular-like (V-like) APs. In the present study, we investigated the membrane currents underlying these two AP types in hESC-CMs. These were generated using standard (Std) and retinoic acid (RA)-based differentiation protocols.
View Article and Find Full Text PDFJ Physiol
August 2025
Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany.
Blebbistatin is an excitation-contraction uncoupling agent commonly used in cardiac optical mapping; however, it has been reported to influence cardiac myofilament Ca sensitivity. As primary contributors to Ca buffering within cardiomyocytes, cardiac myofilaments play a critical role, and even minor disruptions in intracellular Ca buffering significantly alter the free Ca concentration. In this study, we investigated the effect of blebbistatin, a myosin II ATPase inhibitor, on intracellular Ca buffering and cellular electrophysiology in induced pluripotent stem cell-derived atrial cardiomyocytes.
View Article and Find Full Text PDFJ Ginseng Res
September 2025
The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Background: Myocardial hypertrophy is a crucial pathological change that occurs during post-anthracycline treatment cardiomyopathy. The effects of ginsenoside Rb1 (Rb1) on anthracycline-induced hypertrophy remain unclear. This study aimed to explore the antihypertrophic effect of Rb1 on post-doxorubicin (DOX) treatment myocardial hypertrophy and underlying mechanism.
View Article and Find Full Text PDF